PO.7.159 Objective measures of health-related quality of life may not adequately reflect diseaseburden in systemic lupus erythematosus

PO.7.159 Objective measures of health-related quality of life may not adequately reflect diseaseburden in systemic lupus erythematosus

Bibliographic Details
Main Authors:	T Stephens, C Sjöwall, M Björk, A Dominicus, D Eek
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

O20 Lupus low disease activity state and organ damage in relation to quality of life in SLE: a cohort study with up to 11 years of follow-up
by: Christopher Sjöwall, et al.
Published: (2024-03-01)

PO.6.128 Factors associated with survival and discontinuation of antimalarial agents in systemic lupus erythematosus: results from a swedish longitudinal registry
by: I Parodis, et al.
Published: (2022-10-01)

PO.6.119 Low-dose belimumab and antimalarial agents prevent renal flares in systemic lupus erythematosus: results from four randomised clinical trials
by: A Gómez, et al.
Published: (2022-10-01)

PO.7.162 Epidemiology of systemic lupus erythematosus in central Sweden: a population-based cohort study from the östergötland county over 14 years
by: M Saleh, et al.
Published: (2022-10-01)

PO.7.147 Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in patients with systemic lupus erythematosus from a Swedish tertiary referral centre
by: A Gómez, et al.
Published: (2022-10-01)

NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic
by: Jasmin Knopf, et al.
Published: (2022-08-01)

PO.3.59 Echocardiographic abnormalities in systemic lupus erythematosus patients
by: N Guajardo-Jauregui, et al.
Published: (2022-10-01)

PO.1.15 Lupus brain fog: cognitive impairment and depression in systemic lupus erythematosus
by: S Fasano, et al.
Published: (2022-10-01)

LP-159 Studying the disease activity and the degree of internal organ damage in systemic lupus erythematosus patients in the Kazakh population
by: Гульжан Алибекова, et al.
Published: (2023-07-01)

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus
by: Christopher Sjöwall, et al.
Published: (2022-11-01)

PO.1.13 Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus erythematosus
by: P Nilsson, et al.
Published: (2022-10-01)

PO.4.85 What are the sex differences in patients with systemic lupus erythematosus?
by: T Panafidina, et al.
Published: (2022-10-01)

PO.8.182 Pregnancy outcome in saudi women with systemic lupus erythematosus
by: I Al-Homood, et al.
Published: (2022-10-01)

PO.2.30 IGG/IGM autoantibody ratios do not relate to progression from incomplete systemic lupus erythematosus to systemic lupus erythematosus
by: H Bootsma, et al.
Published: (2022-10-01)

PO.4.94 High B-cell polygenic risk is associated with dsDNA antibodies and nephritis in systemic lupus erythematosus
by: S Reid, et al.
Published: (2022-10-01)

PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients
by: JA Roman Ivorra, et al.
Published: (2022-10-01)

PO.1.16 Limbic encephalitis: a rare complication of systemic lupus erythematosus
by: H Khibri, et al.
Published: (2022-10-01)

PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus
by: JA Roman Ivorra, et al.
Published: (2022-10-01)

The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus
by: Helena Enocsson, et al.
Published: (2021-12-01)

P49 Prevalence of neutropenia and association with infections in systemic lupus erythematosus: a Swedish single-center experience over 14 years
by: Christopher Sjöwall, et al.
Published: (2024-03-01)

P150 Temporal trends in treatment patterns in systemic lupus erythematosus in Sweden
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

PO.2.46 Clinical and immunological considerations of ceruloplasmin activity shifts in systemic lupus erythematosus
by: A Trofimenko, et al.
Published: (2022-10-01)

PO.2.43 The activity and damage index in systemic lupus erythematosus depending on antiphospholipid antibodies
by: T Reshetnyak, et al.
Published: (2022-10-01)

PO.8.184 Will there be a pattern of nailfold video-capillaroscopy in patients with systemic lupus erythematosus?
by: S Azevedo, et al.
Published: (2022-10-01)

PO.6.121 Epistemic injustice and educational needs for self-management in systemic lupus erythematosus
by: S Ibañez, et al.
Published: (2022-10-01)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
by: Myriam Martin, et al.
Published: (2017-12-01)

Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes
by: Oliver Skoglund, et al.
Published: (2022-09-01)

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
by: Meriam Hajji, et al.
Published: (2023-06-01)

PO.4.81 Variability of xanthine oxidoreductase activity patterns in systemic lupus erythematosus and rheumatoid arthritis
by: A Trofimenko, et al.
Published: (2022-10-01)

PO.3.57 Correlation between disease activity and echocardiographic parameters in systemic lupus erythematosus patients
by: N Guajardo-Jauregui, et al.
Published: (2022-10-01)

PO.4.82 Correlation between anti ds-dna and systemic lupus erythematosus disease activity
by: N Ajasllari, et al.
Published: (2022-10-01)

PO.7.150 Experience of daily activities among persons with systemic lupus erythematosus with cognitive symptom
by: A Jönsen, et al.
Published: (2022-10-01)

PO.4.84 Infections in infants born to mothers with systemic lupus erythematosus and the role of preterm birth
by: E Svenungsson, et al.
Published: (2022-10-01)

PO.6.125 Mindfulness- based intervention as part of treatment for systemic lupus erythematosus (SLE) patients
by: PR Fortin, et al.
Published: (2022-10-01)

Congenital lupus erythematosus
by: Taseer Ahmed Bhatt, et al.
Published: (2011-01-01)

Systemic lupus erythematosus
by: Witjal Manuel Bermúdez Marrero, et al.
Published: (2017-01-01)

Impaired Microcirculation and Vascular Hemodynamics in Relation to Macrocirculation in Patients With Systemic Lupus Erythematosus
by: Christina Svensson, et al.
Published: (2021-11-01)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Dermoscopy, reflectance confocal microscopy for the noninvasive diagnosis of linear cutaneous lupus erythematosus
by: Hui-Min Meng, et al.
Published: (2023-01-01)

PO.6.123 A rapid decalage of immunosuppressive therapy in a young woman with systemic lupus erythematosus
by: S Salvucci, et al.
Published: (2022-10-01)